BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 29969172)

  • 1. Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy.
    Wong NC; Lam C; Patterson L; Shayegan B
    BJU Int; 2019 Jan; 123(1):51-57. PubMed ID: 29969172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning algorithms can more efficiently predict biochemical recurrence after robot-assisted radical prostatectomy.
    Ekşi M; Evren İ; Akkaş F; Arıkan Y; Özdemir O; Özlü DN; Ayten A; Sahin S; Tuğcu V; Taşçı AI
    Prostate; 2021 Sep; 81(12):913-920. PubMed ID: 34224165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy.
    Tan YG; Fang AHS; Lim JKS; Khalid F; Chen K; Ho HSS; Yuen JSP; Huang HH; Tay KJ
    Prostate; 2022 Feb; 82(3):298-305. PubMed ID: 34855228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve-Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases.
    Thompson JE; Egger S; Böhm M; Siriwardana AR; Haynes AM; Matthews J; Scheltema MJ; Stricker PD
    Eur Urol; 2018 May; 73(5):664-671. PubMed ID: 29273404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing Machine Learning and Automated Performance Metrics to Evaluate Robot-Assisted Radical Prostatectomy Performance and Predict Outcomes.
    Hung AJ; Chen J; Che Z; Nilanon T; Jarc A; Titus M; Oh PJ; Gill IS; Liu Y
    J Endourol; 2018 May; 32(5):438-444. PubMed ID: 29448809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
    Kattan MW; Wheeler TM; Scardino PT
    J Clin Oncol; 1999 May; 17(5):1499-507. PubMed ID: 10334537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
    Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
    Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study.
    Hatano K; Okusa T; Ishizuya Y; Nakai Y; Nakayama M; Kakimoto KI; Nishimura K
    Jpn J Clin Oncol; 2017 Jan; 47(1):74-79. PubMed ID: 27733509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients.
    Bhargava HK; Leo P; Elliott R; Janowczyk A; Whitney J; Gupta S; Fu P; Yamoah K; Khani F; Robinson BD; Rebbeck TR; Feldman M; Lal P; Madabhushi A
    Clin Cancer Res; 2020 Apr; 26(8):1915-1923. PubMed ID: 32139401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
    Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
    J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
    Barocas DA; Salem S; Kordan Y; Herrell SD; Chang SS; Clark PE; Davis R; Baumgartner R; Phillips S; Cookson MS; Smith JA
    J Urol; 2010 Mar; 183(3):990-6. PubMed ID: 20083261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage].
    Rizk J; Ouzzane A; Flamand V; Fantoni JC; Puech P; Leroy X; Villers A
    Prog Urol; 2015 Mar; 25(3):157-68. PubMed ID: 25614075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen screening impacts on biochemical recurrence in patients with clinically localized prostate cancer.
    Hashimoto T; Ohori M; Shimodaira K; Kaburaki N; Hirasawa Y; Satake N; Gondo T; Nakagami Y; Namiki K; Ohno Y
    Int J Urol; 2018 Jun; 25(6):561-567. PubMed ID: 29633374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot-Assisted Radical Prostatectomy: An Evidence-Based Analysis Comparing the Retzius Sparing and Standard Approaches.
    Menon M; Dalela D; Jamil M; Diaz M; Tallman C; Abdollah F; Sood A; Lehtola L; Miller D; Jeong W
    J Urol; 2018 May; 199(5):1210-1217. PubMed ID: 29225060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
    Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
    Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.